FROM THE DESK OF SamGuild

PRESIDENT | AIM AT MELANOMA FOUNDATION

Without research there can be no cure

That’s one of AIM’s guiding principles, and why we created and fund the Melanoma Tissue Bank Consortium and other unique research initiatives

But what we repeatedly hear is that the melanoma community wants more information on the wide range of research being performed and they want to understand how it may help them or future patients The first series we introduced In Plain English has been incredibly popular with our community, and each article is widely and repeatedly read In this series, Dr Kim Margolin, Medical Director, Melanoma Program, Saint John’s Cancer Institute, explains a selected melanoma concept and the current research around it in language that patients and families can easily understand

Last year we debuted the first article in a series called Notes from the Lab, which was also widely read Paul Bunk, a Ph D candidate at Cold Spring Harbor Laboratory, has been our guest writer for this series, which seeks to explore topics in research that’s in its early stages to help the melanoma community understand what might be important in treatment in the upcoming years. Today we introduce another series called Clinical Trials Catch Up, designed to help melanoma patients and their families better understand what kind of treatments are currently in the clinical trial and what looks promising Dr Joshua Mammen, Merle M Musselman Centennial Professor of Surgery, and Chief, Division of Surgical Oncology, University of Nebraska, is our guest writer for this series.

As always, let us know what you think of our newsletters and the information therein We appreciate your feedback and always, your support.